News items are kept on the IHE website for 6 months. If you require an older news item, please contact us at [email protected].
For media inquiries, please contact John Sproule, Senior Policy Director at [email protected]
A national roundtable provides direction for key components that should be included in national strategies to optimize care for patients with progressive fibrosing interstitial lung disease (PF-ILD). The Institute for Health Economics (IHE) conducted an invitational, virtual policy roundtable on progressive fibrosing interstitial lung disease (PF-ILD) on November 20th, 2020. This policy roundtable sought to gain multi-stakeholder consensus on policy directions needed to optimize care for PF-ILD patients that could inform national strategies to address this disease. Progressive, fibrosing interstitial lung disease is a rapidly progressing illness, 50% of patients die, usually from lung failure, between two and five years from the time of diagnosis, with younger patients typically surviving…
The IHE is pleased to receive support from Western Economic Diversification to help Life Sciences companies with promising market-ready innovations to make a stronger economic case for market access. The Institute of Health Economics (IHE) is receiving $953,250 in WD funding over three years to support approximately 30 western Canadian health companies with customized economic analysis that will help to determine the value of their products and technologies. IHE will help companies develop and commercialize innovative products faster by enabling their testing in clinical settings and providing relevant product analysis. Up to approximately 20 products are expected to be developed for market through this initiative. “Health systems are becoming increasingly more rigorous in terms of the economic…
The Royal Society of Canada Working Group on COVID-19 and Economic Recovery, chaired by Dr. Chris McCabe, releases their policy briefing.
The Institute of Health Economics (IHE) is recruiting to support the Health Economics team's growing portfolio of work with government and non-profit research sponsors. We are seeking candidates with experience in economic modelling, to undertake work in the design and conduct of economic evaluations in health care. We would encourage any early and mid-level career professionals to apply for this opportunity. Date of Posting: December 9, 2020 Deadline for Application: January 4, 2021 (all applications received prior to the closing date will be considered; the position will remain open until filled) See full description and application process at the following link: https://www.ihe.ca/about/careers-awards/health-economist-decision-modelling About Institute of Health Economics Institute of Health…
Dr. Chris McCabe, CEO of IHE, along with colleagues Dr. Richard Gold and Dr, Aled Edwards, discuss priorities to support economic recovery post-COVID-19 in an editorial in the November 30th, 2020 Globe and Mail. The priorities identified are
1) labour market transition; 2) climate change; 3) digital services and training; and 4) open science drug discovery. See link below for full article.
“The economy that sustained Canada in the past is not the one that exists today or will be in place tomorrow.”
Link: (external site) : https://www.theglobeandmail.com/canada/article-investing-toward-the-future-rather-than-the-past/
John Sproule Senior Policy Director, Institute of Health Economics Ph: (780) 862-1905 [email protected]